Last Updated: 14 Nov 2024
Executive Summary
HIVE Blockchain Technologies Ltd (HIVE) is a publicly traded company that specializes in blockchain technologies and cryptocurrency mining. The company has a market capitalization of $641.84 million and trades on the NASDAQ exchange under the ticker symbol "HIVE." HIVE's latest stock price is $4.67.
Company Overview
HIVE is a leading provider of blockchain infrastructure and cryptocurrency mining services. The company operates a fleet of high-performance mining rigs and has a diversified portfolio of digital assets. HIVE is committed to providing its customers with the most efficient and reliable blockchain solutions.
Fundamental Analysis
HIVE's financial performance has been mixed in recent quarters. The company reported a net loss of $24.1 million in its most recent quarter, which was wider than the loss reported in the same quarter last year. However, HIVE's revenue increased by 0.37% year-over-year to $123.14 million.
HIVE's profitability metrics are also mixed. The company's gross profit margin was 13.32% in its most recent quarter, which was down from 15.98% in the same quarter last year. HIVE's operating margin was -23.4%, which was also down from -18.1% in the same quarter last year.
HIVE's balance sheet is strong. The company has $241.16 million in cash and equivalents and no long-term debt. HIVE also has a current ratio of 1.56, which indicates that the company is able to meet its short-term obligations.
Technical Analysis
HIVE's stock price has been trending down in recent months. The stock is currently trading below its 50-day and 200-day moving averages. The stock's relative strength index (RSI) is also below 50, which indicates that the stock is oversold.
Short Term Outlook
HIVE's short-term outlook is uncertain. The company's stock price is likely to continue to be volatile in the near term. However, HIVE's strong balance sheet and diversified portfolio of digital assets could provide support for the stock price.
Long Term Outlook
HIVE's long-term outlook is positive. The company is well-positioned to benefit from the growing adoption of blockchain technologies and cryptocurrencies. HIVE's experienced management team and strong financial position should also help the company to succeed in the long term.
Analyst Recommendations
Analysts are mixed on HIVE's stock. Four analysts have a "buy" rating on the stock, while none have a "strong buy" rating. No analysts have a "hold," "sell," or "strong sell" rating on the stock. The average analyst price target for HIVE is $6.20.